Given the documented role of hepatocyte CB1R in insulin resistance [14], our study reinforces the importance CB1R expressed by different types of liver cells in glycemic control and further highlights the therapeutic potential of peripheral CB1R blockade in the metabolic complications of obesity. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.